Update: 17.08.2022
Last week: 31 week 2022 (01.08.2022 - 07.08.2022)
Last full month: July 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 73 186 | -30.9% | 3.7% | -2.4 | 14 615 748 | -29.0% | 3.6% | -2 | 12.9% |
| MoM | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| YTD | 6 582 594 | 16.7% | 6.0% | 0.4 | 1 300 393 084 | 37.9% | 5.7% | 0.7 | 9.8% |
| MAT | 14 210 372 | 38.5% | 6.5% | 1.4 | 2 648 053 422 | 62.7% | 6.1% | 1.5 | 8.9% |
| DEXALGIN | |||||||||
| WoW | 17 387 | -35.0% | 0.4% | -0.3 | 8 048 759 | -30.1% | 1.2% | -0.7 | 9.1% |
| MoM | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| YTD | 1 189 649 | 23.1% | 0.8% | 0.1 | 494 387 687 | 34.8% | 2.1% | 0.3 | 5.5% |
| MAT | 2 062 064 | 9.8% | 0.8% | 0 | 828 485 639 | 18.4% | 2.1% | 0.1 | 3.4% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 55 943 | -20.6% | 47.0% | -6.4 | 29 340 317 | -18.0% | 52.6% | -5.5 | -9.8% |
| MoM | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| YTD | 3 075 497 | 3.6% | 58.1% | -8.4 | 1 552 539 348 | 16.7% | 63.6% | -6.5 | 18.6% |
| MAT | 5 389 515 | 7.7% | 60.9% | -5.2 | 2 646 331 636 | 22.1% | 66.4% | -3.7 | 16.8% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 108 | -2.0% | 34.0% | -2.8 | 13 984 706 | -2.5% | 46.4% | -3.2 | 6.2% |
| MoM | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| YTD | 925 383 | -6.4% | 38.8% | -3.1 | 570 962 440 | -0.1% | 52.2% | -4.6 | 1.0% |
| MAT | 1 599 687 | -8.2% | 39.5% | -1.7 | 970 869 105 | 0.5% | 53.4% | -1.7 | -4.3% |
| FASTUM | |||||||||
| WoW | 14 686 | -3.9% | 0.9% | -0.1 | 8 064 313 | -0.8% | 2.2% | -0.1 | 5.3% |
| MoM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| YTD | 707 257 | -13.9% | 1.2% | -0.2 | 359 865 969 | -4.8% | 2.6% | -0.5 | 2.5% |
| MAT | 1 270 391 | -12.9% | 1.3% | -0.2 | 621 852 843 | -4.8% | 2.8% | -0.4 | 1.2% |
| IODOMARIN | |||||||||
| WoW | 53 055 | 5.8% | 21.8% | 0 | 10 329 384 | 5.0% | 9.7% | -0.2 | 6.0% |
| MoM | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| YTD | 1 799 335 | 6.7% | 18.7% | -0.2 | 362 815 379 | 14.2% | 8.5% | 0 | 7.6% |
| MAT | 3 279 071 | 21.6% | 20.4% | 2.4 | 637 479 673 | 22.9% | 9.3% | 0.8 | 7.4% |
| LIOTON | |||||||||
| WoW | 20 759 | -6.3% | 2.1% | -0.2 | 21 983 650 | -2.7% | 4.3% | -0.4 | 4.7% |
| MoM | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| YTD | 886 804 | -16.6% | 2.5% | -0.3 | 898 916 751 | 5.1% | 4.9% | -0.6 | -5.1% |
| MAT | 1 515 866 | -12.9% | 2.6% | -0.2 | 1 446 535 904 | 6.1% | 5.2% | -0.4 | -5.5% |
| MEZYM | |||||||||
| WoW | 198 441 | -29.8% | 19.4% | -7.4 | 30 225 168 | -31.0% | 13.3% | -5.7 | -2.9% |
| MoM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| YTD | 12 668 254 | 20.9% | 29.1% | 3.1 | 1 939 462 129 | 30.3% | 20.9% | 1.3 | 8.0% |
| MAT | 22 944 911 | 25.3% | 30.8% | 3.9 | 3 360 004 003 | 31.0% | 22.3% | 1.8 | 9.3% |
| MIG 400 | |||||||||
| WoW | 126 481 | -4.4% | 3.1% | -0.4 | 15 031 700 | -2.7% | 2.3% | -0.3 | 9.1% |
| MoM | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| YTD | 5 401 354 | 0.4% | 3.5% | -0.2 | 633 364 138 | 3.6% | 2.7% | -0.3 | 5.5% |
| MAT | 9 913 304 | 9.0% | 3.7% | 0.2 | 1 138 898 417 | 12.0% | 2.9% | 0 | 3.4% |
| PROSTAMOL | |||||||||
| WoW | 17 813 | -14.3% | 14.7% | -2.7 | 25 124 246 | -12.6% | 15.6% | -2.5 | 1.5% |
| MoM | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| YTD | 1 060 686 | -13.8% | 20.4% | -4.2 | 1 489 038 819 | -3.0% | 21.8% | -5.3 | 4.1% |
| MAT | 1 970 446 | -6.3% | 22.1% | -2.3 | 2 653 411 340 | 2.2% | 23.6% | -3.2 | 3.5% |
| RESPERO MYRTOL | |||||||||
| WoW | 12 826 | 18.7% | 9.4% | 0.8 | 5 989 568 | 19.9% | 9.4% | 1 | 8.4% |
| MoM | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
| YTD | 766 056 | 191.3% | 9.1% | 5.7 | 356 758 926 | 182.0% | 8.8% | 4.9 | 9.5% |
| MAT | 1 249 848 | 116.8% | 8.1% | 4 | 575 140 424 | 105.5% | 8.0% | 3.2 | 10.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 582 594 | 16.7% | 6.0% | 0.4 | 1 300 393 084 | 37.9% | 5.7% | 0.7 | 9.8% |
| DEXALGIN | 1 189 649 | 23.1% | 0.8% | 0.1 | 494 387 687 | 34.8% | 2.1% | 0.3 | 5.5% |
| ESPUMISAN (ADULTS) | 3 075 497 | 3.6% | 58.1% | -8.4 | 1 552 539 348 | 16.7% | 63.6% | -6.5 | 18.6% |
| ESPUMISAN BABY | 925 383 | -6.4% | 38.8% | -3.1 | 570 962 440 | -0.1% | 52.2% | -4.6 | 1.0% |
| FASTUM | 707 257 | -13.9% | 1.2% | -0.2 | 359 865 969 | -4.8% | 2.6% | -0.5 | 2.5% |
| IODOMARIN | 1 799 335 | 6.7% | 18.7% | -0.2 | 362 815 379 | 14.2% | 8.5% | 0 | 7.6% |
| LIOTON | 886 804 | -16.6% | 2.5% | -0.3 | 898 916 751 | 5.1% | 4.9% | -0.6 | -5.1% |
| MEZYM | 12 668 254 | 20.9% | 29.1% | 3.1 | 1 939 462 129 | 30.3% | 20.9% | 1.3 | 8.0% |
| MIG 400 | 5 401 354 | 0.4% | 3.5% | -0.2 | 633 364 138 | 3.6% | 2.7% | -0.3 | 5.5% |
| PROSTAMOL | 1 060 686 | -13.8% | 20.4% | -4.2 | 1 489 038 819 | -3.0% | 21.8% | -5.3 | 4.1% |
| RESPERO MYRTOL | 766 056 | 191.3% | 9.1% | 5.7 | 356 758 926 | 182.0% | 8.8% | 4.9 | 9.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 210 372 | 38.5% | 6.5% | 1.4 | 2 648 053 422 | 62.7% | 6.1% | 1.5 | 8.9% |
| DEXALGIN | 2 062 064 | 9.8% | 0.8% | 0 | 828 485 639 | 18.4% | 2.1% | 0.1 | 3.4% |
| ESPUMISAN (ADULTS) | 5 389 515 | 7.7% | 60.9% | -5.2 | 2 646 331 636 | 22.1% | 66.4% | -3.7 | 16.8% |
| ESPUMISAN BABY | 1 599 687 | -8.2% | 39.5% | -1.7 | 970 869 105 | 0.5% | 53.4% | -1.7 | -4.3% |
| FASTUM | 1 270 391 | -12.9% | 1.3% | -0.2 | 621 852 843 | -4.8% | 2.8% | -0.4 | 1.2% |
| IODOMARIN | 3 279 071 | 21.6% | 20.4% | 2.4 | 637 479 673 | 22.9% | 9.3% | 0.8 | 7.4% |
| LIOTON | 1 515 866 | -12.9% | 2.6% | -0.2 | 1 446 535 904 | 6.1% | 5.2% | -0.4 | -5.5% |
| MEZYM | 22 944 911 | 25.3% | 30.8% | 3.9 | 3 360 004 003 | 31.0% | 22.3% | 1.8 | 9.3% |
| MIG 400 | 9 913 304 | 9.0% | 3.7% | 0.2 | 1 138 898 417 | 12.0% | 2.9% | 0 | 3.4% |
| PROSTAMOL | 1 970 446 | -6.3% | 22.1% | -2.3 | 2 653 411 340 | 2.2% | 23.6% | -3.2 | 3.5% |
| RESPERO MYRTOL | 1 249 848 | 116.8% | 8.1% | 4 | 575 140 424 | 105.5% | 8.0% | 3.2 | 10.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 73 186 | -30.9% | 3.7% | -2.4 | 14 615 748 | -29.0% | 3.6% | -2 | 12.9% |
| DEXALGIN | 17 387 | -35.0% | 0.4% | -0.3 | 8 048 759 | -30.1% | 1.2% | -0.7 | 9.1% |
| ESPUMISAN (ADULTS) | 55 943 | -20.6% | 47.0% | -6.4 | 29 340 317 | -18.0% | 52.6% | -5.5 | -9.8% |
| ESPUMISAN BABY | 22 108 | -2.0% | 34.0% | -2.8 | 13 984 706 | -2.5% | 46.4% | -3.2 | 6.2% |
| FASTUM | 14 686 | -3.9% | 0.9% | -0.1 | 8 064 313 | -0.8% | 2.2% | -0.1 | 5.3% |
| IODOMARIN | 53 055 | 5.8% | 21.8% | 0 | 10 329 384 | 5.0% | 9.7% | -0.2 | 6.0% |
| LIOTON | 20 759 | -6.3% | 2.1% | -0.2 | 21 983 650 | -2.7% | 4.3% | -0.4 | 4.7% |
| MEZYM | 198 441 | -29.8% | 19.4% | -7.4 | 30 225 168 | -31.0% | 13.3% | -5.7 | -2.9% |
| MIG 400 | 126 481 | -4.4% | 3.1% | -0.4 | 15 031 700 | -2.7% | 2.3% | -0.3 | 9.1% |
| PROSTAMOL | 17 813 | -14.3% | 14.7% | -2.7 | 25 124 246 | -12.6% | 15.6% | -2.5 | 1.5% |
| RESPERO MYRTOL | 12 826 | 18.7% | 9.4% | 0.8 | 5 989 568 | 19.9% | 9.4% | 1 | 8.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| DEXALGIN | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| ESPUMISAN (ADULTS) | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| ESPUMISAN BABY | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| FASTUM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| IODOMARIN | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| LIOTON | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| MEZYM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| MIG 400 | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| PROSTAMOL | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| RESPERO MYRTOL | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs